| Introducing high-throughput sequencing into mainstream genetic diagnosis practice in inherited platelet disorders JM Bastida, ML Lozano, R Benito, K Janusz, V Palma-Barqueros, ... haematologica 103 (1), 148, 2018 | 118 | 2018 |
| Next-generation sequencing and FISH studies reveal the appearance of gene mutations and chromosomal abnormalities in hematopoietic progenitors in chronic lymphocytic leukemia M Quijada-Álamo, M Hernández-Sánchez, C Robledo, ... Journal of hematology & oncology 10, 1-11, 2017 | 50 | 2017 |
| Two novel variants of the ABCG5 gene cause xanthelasmas and macrothrombocytopenia: a brief review of hematologic abnormalities of sitosterolemia JM Bastida, R Benito, K Janusz, M Díez‐Campelo, ... Journal of Thrombosis and Haemostasis 15 (9), 1859-1866, 2017 | 46 | 2017 |
| Spanish Guidelines for the use of targeted deep sequencing in myelodysplastic syndromes and chronic myelomonocytic leukaemia L Palomo, M Ibanez, M Abáigar, I Vazquez, S Alvarez, M Cabezon, ... British Journal of Haematology 188 (5), 605-622, 2020 | 44 | 2020 |
| Pharmacogenetics and pharmacogenomics as tools in cancer therapy AE Rodríguez-Vicente, E Lumbreras, JM Hernández, M Martín, A Calles, ... Drug metabolism and personalized therapy 31 (1), 25-34, 2016 | 43 | 2016 |
| Mutations in TP53 and JAK2 are independent prognostic biomarkers in B-cell precursor acute lymphoblastic leukaemia M Forero-Castro, C Robledo, R Benito, I Bodega-Mayor, I Rapado, ... British journal of cancer 117 (2), 256-265, 2017 | 41 | 2017 |
| Molecular diagnosis of inherited coagulation and bleeding disorders JM Bastida, R Benito, ML Lozano, A Marín-Quilez, K Janusz, ... Seminars in thrombosis and hemostasis 45 (07), 695-707, 2019 | 38 | 2019 |
| The combination of WGS and RNA-Seq is superior to conventional diagnostic tests in multiple myeloma: Ready for prime time? A Höllein, SO Twardziok, W Walter, S Hutter, C Baer, ... Cancer genetics 242, 15-24, 2020 | 37 | 2020 |
| Chronic lymphocytic leukemia patients with IGH translocations are characterized by a distinct genetic landscape with prognostic implications C Pérez‐Carretero, M Hernández‐Sánchez, T González, ... International Journal of Cancer 147 (10), 2780-2792, 2020 | 29 | 2020 |
| CRISPR/Cas9-generated models uncover therapeutic vulnerabilities of del (11q) CLL cells to dual BCR and PARP inhibition M Quijada-Álamo, M Hernández-Sánchez, V Alonso-Pérez, ... Leukemia 34 (6), 1599-1612, 2020 | 29 | 2020 |
| Splice donor site sgRNAs enhance CRISPR/Cas9-mediated knockout efficiency I García-Tuńón, V Alonso-Pérez, E Vuelta, S Pérez-Ramos, M Herrero, ... PloS one 14 (5), e0216674, 2019 | 29 | 2019 |
| FISHing in the dark: How the combination of FISH and conventional karyotyping improves the diagnostic yield in CpG‐stimulated chronic lymphocytic leukemia AM Dubuc, MS Davids, M Pulluqi, O Pulluqi, K Hoang, ... American Journal of Hematology 91 (10), 978-983, 2016 | 25 | 2016 |
| The presence of genomic imbalances is associated with poor outcome in patients with burkitt lymphoma treated with dose‐intensive chemotherapy including rituximab M Forero‐Castro, C Robledo, E Lumbreras, R Benito, ... British journal of haematology 172 (3), 428-438, 2016 | 25 | 2016 |
| ETV6/RUNX1 Fusion Gene Abrogation Decreases the Oncogenicity of Tumour Cells in a Preclinical Model of Acute Lymphoblastic Leukaemia A Montańo, JL Ordońez, V Alonso-Pérez, J Hernández-Sánchez, ... Cells 9 (1), 215, 2020 | 22 | 2020 |
| Prospective randomized trial of 5 days azacitidine versus supportive care in patients with lower-risk myelodysplastic syndromes without 5q deletion and transfusion-dependent anemia J Sanchez-Garcia, J Falantes, A Medina Perez, F Hernandez-Mohedo, ... Leukemia & Lymphoma 59 (5), 1095-1104, 2018 | 21 | 2018 |
| Co-occurrence of cohesin complex and Ras signaling mutations during progression from myelodysplastic syndromes to secondary acute myeloid leukemia M Martín-Izquierdo, M Abáigar, JM Hernández-Sánchez, D Tamborero, ... Haematologica 106 (8), 2215, 2021 | 18 | 2021 |
| Hidden myelodysplastic syndrome (MDS): A prospective study to confirm or exclude MDS in patients with anemia of uncertain etiology JM Bastida, O López‐Godino, A Vicente‐Sánchez, S Bonanad‐Boix, ... International journal of laboratory hematology 41 (1), 109-117, 2019 | 17 | 2019 |
| Circulating microbial content in myeloid malignancy patients is associated with disease subtypes and patient outcomes J Woerner, Y Huang, S Hutter, C Gurnari, JMH Sánchez, J Wang, ... Nature Communications 13 (1), 1038, 2022 | 13 | 2022 |
| Transcriptomic analysis of patients with immune thrombocytopenia treated with eltrombopag JM Hernández-Sánchez, JM Bastida, D Alonso-López, R Benito, ... Platelets 31 (8), 993-1000, 2020 | 12 | 2020 |
| Dissecting the role of TP53 alterations in del(11q) chronic lymphocytic leukemia M Quijada‐Álamo, C Pérez‐Carretero, M Hernández‐Sánchez, ... Clinical and Translational Medicine 11 (2), e304, 2021 | 11 | 2021 |
